Skip to main content
Premium Trial:

Request an Annual Quote

Kevin Conroy, Maneesh Arora, James Herrman, Gregory Hamilton, John Bellano, Jake Orville, Ondeo Nalco, Leo Burnett, Goran Ando, Trevor Hawkins, Matt Posard, Greg Johnson


Third Wave Technologies this week announced managerial changes associated with CEO Kevin Conroy's recent succession.

Maneesh Arora will transition to the position of chief financial officer by mid-March, the company said. James Herrman will retain the title through the company's annual report filing.

Gregory Hamilton has been named vice president of finance.

John Bellano has been appointed vice president of sales, succeeding Jake Orville. Orville will transition to an as-yet undisclosed position in the company.

Arora joined Third Wave in January 2003 and served, most recently as vice president of marketing and strategy. His previous positions include director of corporate strategy and new ventures and Ondeo Nalco and a range of finance, marketing and sales roles at Kraft Foods.

Hamilton joined the company from Leo Burnett. Prior to that he was an auditor and consultant at Arthur Andersen and Accenture.

Bellano joined Third Wave in February as regional vice president of sales from Roche Diagnostics, where he was a regional business manager since 2000.

Decode this week announced that Goran Ando has resigned from the board of directors. He joined the board in February 2004.

Trevor Hawkins is leaving Tm Bioscience's board, the company said this week. His resignation is due to a "change in employment and relocation to Europe."

Calls to MDS, where Hawkins is chief technology and science officer, were not immediately returned.

Illumina named Matt Posard vice president of marketing, the company said this week.

Posard comes to the company with six years of sales and marketing experience at Biosite. He has also held various marketing positions at GenbProbe.

EraGen has named Greg Johnson, Tracy Marshbanks, and Buce Neviaser to the company's board of directors, EraGen said this week.

Johnson is the managing director of Prolog Ventures.

Tracy Marshbanks is vice president of First Analysis.

Bruce Neviaser is a general partner at Continuum Investment.

Filed under

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.